Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nadira Prashad"'
Autor:
Puja Sapra, Christopher J. O'Donnell, Frank Loganzo, Lioudmila Tchistiakova, Hans-Peter Gerber, Edward Rosfjord, Andreas Giannakou, Xingzhi Tan, L. Nathan Tumey, Tracey Clark, Manoj B. Charati, Nadira Prashad, Russell Dushin, Andreas Maderna, Madan Katragadda, Mauricio Leal, Fan Jiang, Stephane Thibault, Wenyue Hu, Nicole Piché-Nicholas, Jennifer Kahler, Yoon-Chi Han
Purpose:Mortality due to acute myeloid leukemia (AML) remains high, and the management of relapsed or refractory AML continues to be therapeutically challenging. The reapproval of Mylotarg, an anti-CD33–calicheamicin antibody–drug conjugate (ADC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e6151cbf5978586286de379aa6d507
https://doi.org/10.1158/1078-0432.c.6530030
https://doi.org/10.1158/1078-0432.c.6530030
Autor:
Puja Sapra, Christopher J. O'Donnell, Frank Loganzo, Lioudmila Tchistiakova, Hans-Peter Gerber, Edward Rosfjord, Andreas Giannakou, Xingzhi Tan, L. Nathan Tumey, Tracey Clark, Manoj B. Charati, Nadira Prashad, Russell Dushin, Andreas Maderna, Madan Katragadda, Mauricio Leal, Fan Jiang, Stephane Thibault, Wenyue Hu, Nicole Piché-Nicholas, Jennifer Kahler, Yoon-Chi Han
Supplementary tables & figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::158852f333a4ade14168dfd0bff72bfb
https://doi.org/10.1158/1078-0432.22478732.v1
https://doi.org/10.1158/1078-0432.22478732.v1
Autor:
Nikolai Rakhilin, Bing Yang, Mary E. Spilker, Lisa K. Manzuk, Mary Katherine Montgomery, Eyoung Shin, Nadira Prashad, Jungyeon Hwang, Youngho Song, Frank Loganzo, Anand Giddabasappa, Sripad Ram
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society.
Nanoparticle (NP) technology holds significant promise to mediate targeted drug delivery to specific organs in the body. Understanding the 3D biodistribution of NPs in heterogeneous environments such as the tumor tissue can provide crucial informatio
Autor:
Puthenveetil, Sujiet1 sujiet@gmail.com, He, Haiyin1, Loganzo, Frank2, Musto, Sylvia2, Teske, Jesse1, Green, Michael1, Tan, Xingzhi2, Hosselet, Christine2, Lucas, Judy2, Tumey, L. Nathan1, Sapra, Puja2, Subramanyam, Chakrapani1, O’Donnell, Christopher J.1, Graziani, Edmund I.1
Publikováno v:
PLoS ONE. 5/30/2017, Vol. 12 Issue 5, p1-16. 16p.
Publikováno v:
Medical Imaging Week; 6/24/2023, p162-162, 1p
Publikováno v:
AAPS Journal; May2016, Vol. 18 Issue 3, p635-646, 12p
Abstract 935: Generation and preclinical characterization of CD123-CPI antibody-drug conjugate (ADC)
Autor:
Russell Dushin, Fan Jiang, Puja Sapra, Mauricio Leal, Frank Loganza, Lioudmila Tchistiakova, Andreas Maderna, Nadira Anarkali Prashad, Nathan Tumey, Nicole Piche-Nicholas, Hans-Peter Gerber, Luanna Lemon, Manoj Charati, Wendy Hu, Kenny Sung Kyoo Kim, Yoon-Chi Han, Christopher J. O’Donnell, Marc Damelin, Madan Katragadda
Publikováno v:
Cancer Research. 78:935-935
CD123 is expressed on cancer cells in a variety of hematologic malignancies including acute myeloid leukemia (AML). CD123 is frequently expressed on leukemic blasts and leukemic stem cells (LSCs), a cell population associated with relapse in patients
Autor:
Nathan Tumey, Puja Sapra, Nadira Anarkali Prashad, Judy Lucas, Edmund I. Graziani, Frank Loganzo, Frank Barletta, Christopher J. O’Donnell, Lioudmila Tchistiakova, Alison Betts, Hans-Peter Gerber, Kim Marquette, Jon Golas, Manoj Charati, Bitha Narayanan, George Hu, Christine Hosselet, Dangshe Ma
Publikováno v:
Cancer Research. 76:868-868
Antibody-drug conjugates (ADCs) have emerged as an important class of cancer therapeutics. The FDA approval of Kadcyla (T-DM1), a single agent for treatment of HER2-positive advanced metastatic breast cancer, was a significant milestone in the field